Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In this prospective, open-label clinical study is to investigate the behavior of the retinal
functions during development of diabetic macular disease (DME) under the influence of
Lucentis. Measurements with the multifocal electroretinogram (ERG) and microperimetry is used
here as an objective criteria to information about the retinal function obtain.